Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:EVHNASDAQ:GDRXNASDAQ:PGNYNASDAQ:PINC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEVHEvolent Health$7.33-4.1%$9.29$7.06▼$33.63$859.96M1.042.42 million shs955,511 shsGDRXGoodRx$3.81+0.5%$4.33$3.68▼$9.26$1.36B1.241.38 million shs421,522 shsPGNYProgyny$21.34+0.4%$22.10$13.39▼$30.42$1.83B1.371.71 million shs1.07 million shsPINCPremier$22.97+0.3%$20.74$17.23▼$23.56$1.89B0.541.26 million shs3.56 million shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEVHEvolent Health-0.52%-4.67%-17.83%-11.82%-66.87%GDRXGoodRx-1.04%0.00%-18.14%-23.90%-47.87%PGNYProgyny+3.21%+0.28%-6.59%-7.12%-20.32%PINCPremier-0.61%-0.74%+13.37%+26.88%+20.86%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEVHEvolent Health3.0266 of 5 stars4.52.00.00.02.21.70.6GDRXGoodRx3.0751 of 5 stars3.32.00.00.03.41.71.9PGNYProgyny1.1703 of 5 stars1.22.00.00.03.61.71.3PINCPremier2.1444 of 5 stars1.02.02.50.03.62.51.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEVHEvolent Health 3.00Buy$17.79142.81% UpsideGDRXGoodRx 2.64Moderate Buy$6.5571.80% UpsidePGNYProgyny 2.42Hold$23.459.91% UpsidePINCPremier 2.00Hold$22.20-3.35% DownsideCurrent Analyst Ratings BreakdownLatest EVH, PGNY, PINC, and GDRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/21/2025PINCPremierPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$19.00 ➝ $24.005/15/2025PINCPremierRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$19.00 ➝ $22.005/13/2025EVHEvolent HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $15.005/13/2025GDRXGoodRxUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.255/12/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$23.00 ➝ $21.005/9/2025EVHEvolent HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$14.00 ➝ $15.005/9/2025GDRXGoodRxThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.005/8/2025PINCPremierCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$19.00 ➝ $22.004/29/2025GDRXGoodRxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$8.00 ➝ $7.004/28/2025EVHEvolent HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$13.00 ➝ $13.004/10/2025EVHEvolent HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $14.00(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEVHEvolent Health$2.40B0.36$1.22 per share6.00$9.38 per share0.78GDRXGoodRx$797.41M1.71$0.32 per share11.77$1.93 per share1.97PGNYProgyny$1.21B1.51$0.60 per share35.58$5.77 per share3.70PINCPremier$1.26B1.50$4.42 per share5.20$18.81 per share1.22Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEVHEvolent Health-$113.04M-$1.23N/AN/AN/A-2.41%5.73%2.36%8/14/2025 (Estimated)GDRXGoodRx-$8.87M$0.08N/A21.172.46-2.05%5.35%2.51%8/14/2025 (Estimated)PGNYProgyny$62.04M$0.5736.7932.832.395.03%11.36%7.87%8/5/2025 (Estimated)PINCPremier$119.54M$0.57N/A17.27N/A-0.40%9.41%5.38%N/ALatest EVH, PGNY, PINC, and GDRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025EVHEvolent Health$0.08$0.06-$0.02-$0.63$460.15 million$483.65 million5/8/2025Q1 2025PGNYProgyny$0.45$0.17-$0.28$0.17$307.86 million$324.04 million5/7/2025Q1 2025GDRXGoodRx$0.04$0.09+$0.05$0.03$202.25 million$202.97 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEVHEvolent HealthN/AN/AN/AN/AN/AGDRXGoodRxN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/APINCPremier$0.843.66%+2.50%147.37%N/ALatest EVH, PGNY, PINC, and GDRX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/24/2025PINCPremierquarterly$0.214.2%5/30/20256/1/20256/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEVHEvolent Health0.581.041.04GDRXGoodRx0.705.485.48PGNYProgynyN/A2.622.62PINCPremierN/A0.830.83Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEVHEvolent HealthN/AGDRXGoodRx63.77%PGNYProgyny94.93%PINCPremier74.41%Insider OwnershipCompanyInsider OwnershipEVHEvolent Health1.60%GDRXGoodRx4.53%PGNYProgyny9.40%PINCPremier0.96%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEVHEvolent Health5,100117.40 million114.70 millionOptionableGDRXGoodRx950357.17 million365.25 millionOptionablePGNYProgyny31085.72 million74.68 millionOptionablePINCPremier2,60082.34 million90.43 millionOptionableEVH, PGNY, PINC, and GDRX HeadlinesRecent News About These CompaniesPremier American Uranium Positioned for U.S. Nuclear Resurgence Amid Transformational Policy ShiftMay 27 at 2:37 PM | globenewswire.comMillennium Management LLC Grows Holdings in Premier, Inc. (NASDAQ:PINC)May 27 at 3:38 AM | marketbeat.com91,315 Shares in Premier, Inc. (NASDAQ:PINC) Acquired by Man Group plcMay 26 at 3:58 AM | marketbeat.comAmeriprise Financial Inc. Has $5.65 Million Stock Holdings in Premier, Inc. (NASDAQ:PINC)May 26 at 3:03 AM | marketbeat.comPremier (NASDAQ:PINC) Stock Price Expected to Rise, Piper Sandler Analyst SaysMay 23, 2025 | marketbeat.comPremier, Inc. (NASDAQ:PINC) Shares Sold by Bank of America Corp DEMay 23, 2025 | marketbeat.comWBI Investments LLC Buys Shares of 21,398 Premier, Inc. (NASDAQ:PINC)May 22, 2025 | marketbeat.comDeutsche Bank AG Purchases 140,367 Shares of Premier, Inc. (NASDAQ:PINC)May 22, 2025 | marketbeat.comBNP Paribas Financial Markets Acquires 46,302 Shares of Premier, Inc. (NASDAQ:PINC)May 21, 2025 | marketbeat.comOccudo Quantitative Strategies LP Purchases Shares of 10,825 Premier, Inc. (NASDAQ:PINC)May 20, 2025 | marketbeat.comLazard Asset Management LLC Grows Stock Position in Premier, Inc. (NASDAQ:PINC)May 20, 2025 | marketbeat.comEthic Inc. Buys Shares of 11,746 Premier, Inc. (NASDAQ:PINC)May 20, 2025 | marketbeat.comPINC Q1 Earnings Call: Revenue Tops Estimates Amid Tariff and Margin PressuresMay 19, 2025 | msn.comQuantinno Capital Management LP Boosts Holdings in Premier, Inc. (NASDAQ:PINC)May 18, 2025 | marketbeat.comRedwood Investment Management LLC Makes New $3.66 Million Investment in Premier, Inc. (NASDAQ:PINC)May 17, 2025 | marketbeat.comNorthern Trust Corp Has $15.73 Million Stake in Premier, Inc. (NASDAQ:PINC)May 17, 2025 | marketbeat.comShould Value Investors Buy Premier (PINC) Stock?May 16, 2025 | zacks.comPremier’s 15 Top Health Systems for 2025May 15, 2025 | msn.comSaint Joseph Health recognized as a Top 15 Health SystemMay 15, 2025 | lanereport.comPremier Announces the Nation’s 15 Top Health Systems®May 15, 2025 | finance.yahoo.comPremier Announces the Nation's 15 Top Health Systems®May 15, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEVH, PGNY, PINC, and GDRX Company DescriptionsEvolent Health NYSE:EVH$7.32 -0.32 (-4.12%) Closing price 03:59 PM EasternExtended Trading$7.51 +0.19 (+2.53%) As of 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.GoodRx NASDAQ:GDRX$3.81 +0.02 (+0.53%) Closing price 04:00 PM EasternExtended Trading$3.80 0.00 (-0.13%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.Progyny NASDAQ:PGNY$21.34 +0.09 (+0.42%) Closing price 04:00 PM EasternExtended Trading$21.34 0.00 (0.00%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.Premier NASDAQ:PINC$22.97 +0.08 (+0.35%) Closing price 04:00 PM EasternExtended Trading$22.74 -0.23 (-1.02%) As of 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; and STOCKD, an e-commerce platform, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is based in Charlotte, North Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hormel Stock Near Lows, But Tariff Relief Could Boost Outlook Salesforce’s Stock Price Presents an Opportunity to Buy NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Intel's Loss Is Broadcom's Gain as AVGO Dominates Networking Target's Big Bet: Is It a Cheap Stock or a Value Trap? Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
